For the first time in over four decades, researchers are returning to examining the therapeutic benefits of mind altering substances, including MDMA (ecstasy), psilocybin (mushrooms), marijuana and LSD. In the 1970s the study of all psychedelics was criminalized in the US, despite emerging evidence of their medical value. Over the past decade, the Multidisciplinary Association for Psychedelic Research (MAPS) has helped to revive psychedelic research, sponsoring studies across the United States and around the world, including MDMA-assisted therapy for PTSD, and end-of-life anxiety. The results have been very positive, lasting over 72 months of follow-up, with few adverse effects. Psychedelics may promote a deepening and acceleration of the psychotherapeutic process. During therapy, people often are able to access and find peace with disavowed, "exiled" parts of themselves. In this recording, the Principal Investigator of the Phase I and II level trials will discuss outcomes and processes.
NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after completing the on-line post-test (80% passing score) and completing the evaluation).
Continuing Education Information: Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, please contact cepesi@pesi.com or 800-844-8260 before the event.
Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.
This self-study activity consists of 3.5 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc. is an approved provider with the Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling. Provider Number 50-399. This self-study course qualifies for 3.5 continuing education credits.
This intermediate self-study activity consists of 3.5 clock hours of continuing education instruction. Per the IDFPR: Social Work Continuing Education Sponsors approved by the Division in accordance with the rules for the administration of Clinical Social Work and Social Work Practice Act (225 ILCS 201), 68 Ill. Adm. Code 1470.95; PESI, Inc. is a registered social work continuing education sponsor with the Department of Financial and Professional Regulation, Division of Professional Regulation. License #: 159-000154. A certificate of attendance will be awarded at the end of the program to participants who are in full attendance, pass a post-test, and who complete the program evaluation.
CE credit is available. This self-study course consists of 4.25 continuing education credit hours for Kentucky Counselors. The Continuing Education Requirements for the Kentucky Board of Licensed Professional Counselors (201 KAR 36:030 Section 2) state continuing education programs from providers sponsored or approved by a state counseling licensure board shall be approved without further review by the board. PESI, Inc. is approved by the South Carolina Board of Examiners for Licensure of Professional Counselors, Marriage and Family Therapists, and Psycho-Educational Specialists. Provider #4540. PESI maintains responsibility for this program and its contents.
The Montana Board of Behavioral Health no longer pre-approves any courses or sponsors. Each licensee is responsible for taking courses which contribute to their competence and directly relate to their scope of practice as defined in board statute (MAR 24-219-32). Licensees must keep CE documentation for three years in case of an audit. This intermediate level self-study activity consists of 3.5 clock hours of instruction.
PESI, Inc. is an approved CEU provider with the State of Nevada Board of Examiners for Marriage and Family Therapists and Clinical Professional Counselors. This self-study activity qualifies for 3.5 contact hours. Approved Provider # NVCEP2006.
This self-study program has been approved for 3.5 continuing education hours by the South Carolina Board of Examiners for Licensure of Professional Counselors, Marriage and Family Therapists, and Psycho-Educational Specialists. Provider #4540.
This self-study activity consists of 3.5 clock hours of continuing education instruction. Texas State Board of Examiners of Professional Counselors no longer approves programs or providers. PESI activities meet the continuing education requirements as listed in Title 22 Texas Administrative Code, Chapter 681, Subchapter J, Section 681.142 Acceptable Continuing Education. Please retain the certificate of completion that you receive and use as proof of completion when required.
This intermediate self-study activity consists of 3.5 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc. is an approved provider with the Colorado Chapter of the National Association of Social Workers. Provider #1413. This self-study course has been approved for 3.5 continuing education hours.
COLORADO PARTICIPANTS ONLY: If you did not answer YES to be reported to the Colorado Chapter of the NASW on the evaluation, please contact cepesi@pesi.com and provide the full title of the webcast, speaker name, date of live broadcast, your name and your license number in the email.
PESI, Inc. is an approved provider with the Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling. Provider Number 50-399. This self-study course qualifies for 3.5 continuing education credits.
PESI, Inc. is an approved provider with the State of Illinois, Department of Financial and Professional Regulation, Division of Professional Regulation. License #: 159-000154. Successful completion of this self-study activity qualifies for 3.5 contact hours.
PESI, Inc. is an approved provider with the Kansas Behavioral Sciences Regulatory Board. Provider #14-006. This self-study course has been approved for 3.5 continuing education hours.
PESI, Inc. is an approved provider with the State of Minnesota, Board of Social Work. Provider #: CEP-140. This self-study package has been approved for 3.5 continuing education hours. This certificate has been issued upon successful completion of a post-test.
The Montana Board of Behavioral Health no longer pre-approves any courses or sponsors. Each licensee is responsible for taking courses which contribute to their competence and directly relate to their scope of practice as defined in board statute (MAR 24-219-32). Licensees must keep CE documentation for three years in case of an audit. This intermediate level self-study activity consists of 3.5 clock hours of instruction.
PESI, Inc. is approved by the Canadian Psychological Association to offer continuing education for psychologists. PESI, Inc. maintains responsibility for the program. This program is approved for 3.5 self-study continuing education hours. Full credit statement at: www.pesi.com/cpa-statement
PESI, Inc., is an approved provider with the Florida Board of Psychology.Provider Number #50-399.This product qualifies for 3.5 self-study continuing education credits.
This self-study activity consists of 3.5 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from this self-study activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc is an approved provider with the State of Illinois, Department of Professional Regulation. License #: 268.000102. Full attendance at this self-study course qualifies for 3.5 contact hours.
PESI, Inc. is approved by the Kentucky Board of Examiners of Psychology to offer continuing education for psychologists, approved provider #202312H. PESI maintains responsibility for this program and its content. This self-study activity will qualify for 3.5 contact hours.
PESI, Inc. is approved by the Ohio Psychological Association, Provider #263896894, to sponsor continuing education for psychologists. PESI, Inc. maintains responsibility for this program and its content. PESI is offering this self-study activity for 3.5 Standard hours of continuing education credit.
PESI, Inc. is approved by the Pennsylvania State Board of Psychology to offer continuing education for psychologists. Provider #PSY000211. PESI maintains responsibility for the program(s). This self-study program qualifies for 3.5 continuing education hours.
This self-study activity consists of 3.5 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save this course outline, the certificate of completion you receive from this self-study activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc. is an approved provider with the Florida Board of Clinical Social Work, Marriage and Family Therapy and Mental Health Counseling. Provider Number 50-399. This self-study course qualifies for 3.5 continuing education credits.
PESI, Inc. has been approved as a provider of continuing education by the State of Illinois, Department of Professional Regulation. Provider #:168-000156. Full attendance at this self-study activity qualifies for 3.5 credits.
The Montana Board of Behavioral Health no longer pre-approves any courses or sponsors. Each licensee is responsible for taking courses which contribute to their competence and directly relate to their scope of practice as defined in board statute (MAR 24-219-32). Licensees must keep CE documentation for three years in case of an audit. This intermediate level self-study activity consists of 3.5 clock hours of instruction.
PESI, Inc. is an approved CEU provider with the State of Nevada Board of Examiners for Marriage and Family Therapists and Clinical Professional Counselors. This self-study activity qualifies for 3.5 contact hours. Approved Provider # NVCEP2006.
This self-study program has been approved for 3.5 continuing education hours by the South Carolina Board of Examiners for Licensure of Professional Counselors, Marriage and Family Therapists, and Psycho-Educational Specialists. Provider #4540.
This self-study activity consists of 3.5 clock hours of continuing education instruction. Texas State Board of Examiners of Marriage and Family Therapists no longer approves programs or providers. PESI activities meet the continuing education requirements as listed in Title 22 of the Texas Administrative Code, Chapter 801, Subchapter K, Section 801.264 Types of Acceptable Continuing Education. Please retain the certificate of completion that you receive and use as proof of completion when required.
This self-study activity consists of 3.5 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from the activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc. is an approved provider by the CADTP, Provider #: 201. This Category H activity meets the qualifications for 3.5 CEU's (continuing education hours).
Provider #120924. This course has been approved as a CCB approved training and has been awarded 3.5 hours by the Connecticut Certification Board.
PESI, Inc. is an Oklahoma Board of Licensed Alcohol and Drug Counselors approved provider #20240032. This self-study activity consists of 3.5 clock hours of continuing education instruction.
This self-study activity consists of 3.5 clock hours of continuing education instruction. Credit requirements and approvals vary per state board regulations. Please save the course outline, the certificate of completion you receive from this self-study activity and contact your state board or organization to determine specific filing requirements.
PESI, Inc. is a provider approved by the California Board of Registered Nursing, Provider #: 17118 for 3.5 self-study contact hours.
** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.
PESI, Inc. is an approved provider by the Florida Board of Nursing. Provider #: FBN2858. These materials qualify for 3.5 self-study contact hours.
PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 3.5 self-study contact hours. Please email cepesi@pesi.com with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.
This self-study program has been approved for 3.5 continuing education hours by the South Carolina Board of Examiners for Licensure of Professional Counselors, Marriage and Family Therapists, and Psycho-Educational Specialists. Provider #4540.
This self-study activity qualifies for 3.5 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.
| File type | File name | Number of pages | |
|---|---|---|---|
| Manual - The Use of Mind-Altering Substances (5 MB) | 44 Pages | Available after Purchase |
Michael Mithoefer, MD, clinical assistant professor of psychiatry at the Medical University of South Carolina. In 2009, he completed & published the first FDA approved clinical trial of MDMA assisted psychotherapy for treatment-resistant PTSD, followed by completion of a Phase II trial. He is overseeing a multisite Phase III study of MDMA-assisted psychotherapy in 13 sites around the US (including the Trauma Research Foundation), and another MDMA-assisted psychotherapy multisite study in Europe and Israel.
Speaker Disclosures:
Ismail Lourido Ali, JD, is Director of Policy and Advocacy for the Multidisciplinary Association for Psychedelic Studies (MAPS), a founding board member of the Psychedelic Bar Association, and former Chair of the Board of Directors for Students for Sensible Drug Policy.
Speaker Disclosures:
Financial: Ismail Ali is the policy and advocacy director for Multidisciplinary Association for Psychedelic Studies. He receives a speaking honorarium from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Ismail Ali works as an activist for compassionate drug policies. He is the founding board member of the Psychedelic Bar Association.
Brian D. Richards, PsyD, completed a master’s degree in Existential-Phenomenological Psychology at Duquesne University, a PsyD at the University of Denver School for Professional Psychology, and a Postdoctoral Fellowship at the Johns Hopkins Behavioral Pharmacology Research Unit, where he contributed to some of the original research administering psilocybin with cancer patients and healthy normal adults. Dr. Richards was formerly a Clinical Director with MedOptions, the largest behavioral health provider in the United States. He also provides Advanced Screenings at Oasis, an acute outpatient center in Maryland, and cares for patients with a cancer diagnosis at Maryland oncology Hematology, The Aquilino Cancer Center. Dr. Richards was a Lead Trainer and Mentor for Compass Pathways (a UK-based Life Sciences Company), and he also mentors students at the California Institute for Integral Studies, the leading Psychedelic Medicine Certificate Program worldwide.
Speaker Disclosures:
Financial: Dr. Brian Richards has employment relationships with the Center for Psychedelic Therapies and Research, Maryland Oncology Hematology, Sunstone Medical, Johns Hopkins University School of Medicine, and the Oasis the Center for Mental Health. He receives a speaking honorarium from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Brian Richards has no relevant non-financial relationships.
Gita Vaid, MD, is a board-certified psychiatrist and psychoanalyst and co-founder of the Center for Natural Intelligence, a multidisciplinary laboratory dedicated to psychedelic psychotherapy innovation and clinical practice. A lead instructor at The Ketamine Training Center and a member of the Mount Sinai Psychedelic Psychotherapy Research and Trauma Center, she is a Multidisciplinary Association for Psychedelic Studies-trained psychedelic psychotherapist practicing ketamine-assisted psychotherapy in New York City. Vaid completed her residency training at NYU Medical Center and psychoanalytic training at the Psychoanalytic Association of New York. She trained as a fellow in clinical psychopharmacology and neurophysiology at New York Medical College and completed a research fellowship at NYU Medical Center.
Speaker Disclosures:
Financial: Dr. Gita Vaid maintains a private practice and has employment relationships with the Ketamine Training Center Faculty, New York University, and Mind Medicine Australia. She receives a speaking honorarium from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Gita Vaid is a member of the American Psychoanalytic Association and the American Psychiatric Association.
Rachel Yehuda, PhD, Professor of Psychiatry and Neuroscience, is the Director of the Center for Psychedelic Psychotherapy and Trauma Research. She is also Director of the Traumatic Stress Studies Division at the Mount Sinai School of Medicine, which includes the PTSD clinical research program and the Neurochemistry and Neuroendocrinology laboratory the James J. Peters Veterans Affairs Medical Center. Dr. Yehuda is a recognized leader in the field of traumatic stress studies.
She has authored more than 450 published papers, chapters, and books in the field of traumatic stress and the neurobiology of PTSD. Her current interests include the study of risk and resilience factors, psychological and biological predictors of treatment response in PTSD, genetic and epigenetic studies of PTSD and the intergenerational transmission of trauma an PTSD. She has an active federally-funded clinical and research program that welcomes local and international students and clinicians.
Speaker Disclosures:
Financial: Dr. Rachel Yehuda has an employment relationship with the Icahn School of Medicine at Mount Sinai and the Department of Veterans Affairs. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Rachel Yehuda is a member of the International Society for Traumatic Stress Studies, the International Society for Neuroscience, and the Anxiety Disorder Association of America. She serves on the scientific advisory board for the National Anxiety Foundation. Dr. Yehuda is an ad hoc grant reviewer for the VA Merit Review Committee, the Department of Defense (DOD), and the National Institute of Mental Health (NIMH).
Rick Doblin, PhD, is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS). His professional goal is to help develop legal contexts for the beneficial uses of psychedelics and marijuana, primarily as prescription medicines but also for personal growth for otherwise healthy people, and eventually to become a legally licensed psychedelic therapist. He founded MAPS in 1986, and currently resides in Boston with his wife and dog.
Speaker Disclosures:
Anne Wagner, PhD, CPsych, Adjunct Professor, Department of Psychology & Associate Member, Yeates School of Graduate Studies at Ryerson University, Toronto. Trainer in CBCT and CPT. Team member, MDMA trial for Cognitive Behavioral Conjoint Therapy (CBCT) for PTSD. Founder of Remedy (www.remedycentre.ca), a centre for mental health innovation.
Speaker Disclosures:
Financial: Anne Wagner is the founder of Remedy and Remedy Institute. She has employment relationships with Toronto Metropolitan University, Maya Atlas, and Multidisciplinary Association for Psychedelic Studies Public Benefit Corporation. She receives compensation as a trainer, collaborator, and consultant. She receives grants from Philanthropic Donors and the Australian National Health and Medical Research Council Innovative. Anne Wagner is a consultant with Lykos Therapeutics. She receives a speaking honorarium and recording royalties from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Anne Wagner is a member of the Canadian Psychological Association, the International Society of Traumatic Stress Studies, and Association for Behavioral and Cognitive Therapies. She is an Ad hoc reviewer and editor for several peer review journals, for a complete list contact PESI, Inc.
James W. Hopper, PhD, Independent consultant and Instructor in Psychology, Cambridge Health Alliance & Harvard Medical School. Co-editor, Mindfulness-Oriented Interventions for Trauma: Integrating Contemplative Practices. The MDMA Team, Trauma Research Foundation.
Speaker Disclosures:
Financial: James Hopper maintains a private practice and has employment relationships with Harvard University and Cambridge Health Alliance. He receives royalties as a published author. James Hopper receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: James Hopper serves on the advisory board for Callisto. He is a member of the International Society for Traumatic Stress Studies and the APA Division 56. James Hopper is an Ad hoc reviewer for several peer review journals, for a complete list contact PESI, Inc.
Elizabeth Call, PsyD, offers psychotherapy services to those dealing with life transitions, loss, anxiety, dysthymia, and post-traumatic stress. A psychologist for over 20 years, she utilizes Eye Movement Desensitization and Reprocessing, or EMDR, in her practice as well as Internal Family Systems (IFS) Therapy. Throughout her extensive career, Elizabeth Call, PsyD, has served in multiple capacities in mental health facilities in Massachusetts and Arizona. She is also a former instructor in Harvard Medical School’s Department of Psychiatry.
Speaker Disclosures:
Financial: Dr. Elizabeth Call maintains a private practice, is the co-founder of Burma Border Projects, and has employment relationships with EMDR International Association and EMDR Institute. She is a sub-investigator for FDA phase III trials of MDMA-assisted psychotherapy sponsored by MAPS/MPBC and The Trauma Research Foundation. Dr. Call receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Elizabeth Call is a member of the EMDR International Association and the Massachusetts Psychological Association.
Susan Walker, MD, Instructor in Psychiatry, Harvard Medical School. Child and Adolescent Psychiatrist, Cambridge health Alliance. MDMA Therapy Team Member, the Trauma Research Foundation. Co-principal Investigator, Boston Site of MAPS sponsored MDMA for PTSD study.
Speaker Disclosures:
Financial: Susan Walker is a clinical sub-investigator and therapist with MAPS/MPBC and The Trauma Research Foundation. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Susan Walker is a member of the American Psychiatric Association and American Psychiatric Association.
Francis Guerriero, MA, LICSW, Private practice, Cambridge, MA; MDMA Therapy team member, The Trauma Research Foundation.
Speaker Disclosures:
Financial: Francis Guerriero maintains a private practice and has an employment relationship with the Trauma Research Foundation. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Francis Guerriero has a professional relationship as a therapist and sub-investigator under Multidisciplinary Association for Psychedelic Studies (MAPS).
Michael D. Alpert, MD, Staff Psychiatrist, BayCove Mental Health Center, Boston Harvard Medical School; MDMA Therapy team member, the Trauma Research Foundation.
Speaker Disclosures:
Financial: Dr. Michael Alpert maintains a private practice and has employment relationships with Quincy Asian Resources Initiative, Melrose-Wakefield Hospital, and Cambridge Health Alliance. He receives a consulting fee from Lykos Therapeutics and Odyssey PBC. Dr. Alpert receives a speaking honorarium and recording royalties from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Dr. Michael Alpert is a member of the American Psychiatric Association and the Massachusetts Medical Society.
Bessel A. van der Kolk, MD, is a clinician, researcher and teacher in the area of post-traumatic stress. His work integrates developmental, neurobiological, psychodynamic and interpersonal aspects of the impact of trauma and its treatment.
Dr. van der Kolk and his various collaborators have published extensively on the impact of trauma on development, such as dissociative problems, borderline personality and self-mutilation, cognitive development, memory, and the psychobiology of trauma. He has published over 150 peer-reviewed scientific articles on such diverse topics as neuroimaging, self-injury, memory, neurofeedback, Developmental Trauma, yoga, theater, and EMDR.
He is founder of the Trauma Center in Brookline, Massachusetts and President of the Trauma Research Foundation, which promotes clinical, scientific, and educational projects.
His 2014 #1 New York Times best seller, The Body Keeps the Score: Brain, Mind, and Body in the Treatment of Trauma, transforms our understanding of traumatic stress, revealing how it literally rearranges the brain’s wiring – specifically areas dedicated to pleasure, engagement, control, and trust. He shows how these areas can be reactivated through innovative treatments including neurofeedback, somatically based therapies, EMDR, psychodrama, play, yoga, and other therapies.
Dr. van der Kolk is the past president of the International Society for Traumatic Stress Studies, and professor of psychiatry at Boston University Medical School. He regularly teaches at conferences, universities, and hospitals around the world.
Speaker Disclosures:
Access never expires for this product.
For a more detailed outline that includes times or durations of time, if needed, please email cepesi@pesi.com
Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info
Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.
ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.
PESI Mobile App
Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.
Please wait ...
